Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CVM is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: neutral
Last trade: buy 50 days ago
Red flags: 0
40 filers reported a long position in CVM for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $595.4K | 572.5K | +1,495% |
| VANGUARD CAPITAL MANAGEMENT LLC | $564.8K | 543.1K | +122.9% |
| CITADEL ADVISORS LLC | $206.4K | 198.5K | New |
| MAI Capital Management | $112.6K | 108.3K | +18.6% |
| GEODE CAPITAL MANAGEMENT, LLC | $91.8K | 88.2K | +3.4% |
| COMMONWEALTH EQUITY SERVICES, LLC | $53.5K | 51.4K | +191.9% |
| HRT FINANCIAL LP | $53K | 51.2K | New |
| VANGUARD FIDUCIARY TRUST CO | $51K | 49K | Unchanged |
| BlackRock, Inc. | $45K | 43.3K | Unchanged |
| BANK OF AMERICA CORP /DE/ | $42.6K | 40.9K | -0.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.